precious-metals-investing LAURION Strengthens its Technical Leadership at Ishkoday with Appointment of Pierre-Jean Lafleur, P.Eng., as Qualified Person
precious-metals-investing LAURION Provides Strategic Update for 2026: Advancing Ishkoday through Disciplined Execution
precious-metals-investing LAURION Intersects High-Grade Gold, Silver and Zinc at Ishkoday A-Zone/McLeod/CRK Zone, Confirming Structural Continuity Along Mineralized Corridor
precious-metals-investing LAURION Reports Multiple High-Grade Intercepts, Including 15.35 g/t Au over 0.50 m , 7.30 g/t Au over 0.50 m , and a Broad 3.0 m Interval of 1.09 g/t Au
precious-metals-investing LAURION Extends Drilling into Untested Ground Linking Brenbar and Sturgeon River Mine Corridors at Ishkoday
gold-investing LAURION Broadens Advisor Network and Issues Stock Options to First Nations under Amended Exploration Agreement as Ishkoday Exploration Progresses
gold-investing LAURION Starts defining Gold Mineralization North and Northeast of the Brenbar Shaft, Highlighting 2.68 g/t Au over 1.05 m from 117.6 m to 118.65 m
precious-metals-investing LAURION Launches 1,700-Metre Follow-Up Drill Program to Delineate and Expand Near-Surface Gold and Base-Metal Zones at Ishkoday
precious-metals-investing LAURION Announces Frankfurt Stock Exchange Listing and Corporate Awareness Agreements
precious-metals-investing LAURION Reports 32.47 g/t Gold Over 1.90 m, including 67.8 g/t Gold Over 0.90 m in Channel Sample at Twin Falls, Ishkoday Project
precious-metals-investing LAURION Unlocks High-Grade Gold up to 16.00 g/t in West Vein Systems of the Sturgeon River Mine Area
precious-metals-investing Laurion Strengthens Its Board With Appointment of Vikram Jayaraman as a New Director
FDA Accepts LEQEMBI® IQLIK Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease under Priority Review
FDA Accepts LEQEMBI® IQLIKTM Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease under Priority Review
Data at 2026 Boswick Burn & Wound Symposium highlight first integrated use of AVITA Medical technologies
CORRECTION - Domestic Metals Engages ICP Securities Inc. for Automated Market Making Services and provides further details on the engagement of Michael Pound
